Influence of early or late referal to nephrologist over morbidity and mortality in hemodialysis;Referencia precoz y tardía al nefrólogo, su influencia en la morbi-mortalidad en hemodiálisis

Nefrologia

Volumn 23, Issue 3, 2003, Pages 234-242

  Gallego, E ^a   Lopez A ^a   Lorenzo, I ^a   Lopez E ^a   Llamas, F ^a   Illescas, M L ^a   Andres E ^a   Serrano, A ^a   Olivas, E ^a   Gomez Roldan C ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

Chronic renal failure; Hemodialysis; Referral; Survival

Indexed keywords

ADULT; ANEMIA; ARTICLE; BLOOD LEVEL; COMORBIDITY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; NEOPLASM; NUTRITION; PATIENT REFERRAL; STATISTICAL SIGNIFICANCE; SURVIVAL; VASCULAR DISEASE; VEIN CATHETERIZATION; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; NEPHROLOGY; RENAL REPLACEMENT THERAPY; RISK; TIME; TREATMENT OUTCOME;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROLOGY; RENAL DIALYSIS; RISK; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 4544358445     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Comité de Registro de la SEN y Registros Autonómicos: Informe de diálisis y trasplante de la Sociedad Española de Nefrología y Registros autonómicos correspondientes al año 1999. Nefrología 21: 246-252, 2001.
2. US Renal Data System, USRDS 1999 Annual Data Report: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 34 (Supl. 1): 1-151, 1999.
3. Comité de Registre de la SEN: Registro nacional de diálisis y trasplante de la sociedad Española de Nefrología. Informe 1990. Nefrología 12: 471-484, 1992.
4. Mailloux LU, Bellucci AG, Napolitano B, Mossey T, Wilkes BM, Bluestone PA: Survival estimates for 683 patients starting dialysis from 1970 trough 1989: identification of risk factors for survival. Clinical Nephrology 42: 127-135, 1994.
5. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 24: 1010-1018, 1994.
6. Khan IH: Comorbidity: the mayor challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transplant 13 (Supl. 1): 76-79, 1998.
7. Held PJ, Port FK, Wolfe RA, Stannard DC, Carrol CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakin RH, Agodoa L: The dose of hemodialysis and patient mortality. Kidney Int 50: 550-556, 1996.
8. Hakim RH, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT, Agodoa L: Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 50: 566-570, 1996.
9. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31: 997-1006, 1998.
10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE: The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28: 53-61, 1996.
11. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617, 1998.
12. Mazzuchi N, Carbonel E, Fernández-Cean J: Importance of blood pressure control in hemodialysis patient survival. Kidney Int 58: 2147-2154, 2000.
13. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival end-stage renal disease. Circulation 99: 2434-2439, 1999.
14. Silberberg JS, Barre PE, Prichard S, Sniderman AD: Impact of left ventricular hypertrophy on survival in end stage renal diseases. Kidney Int 36: 286-290, 1989.
15. Obrador GT, Pereira BJG: Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31: 398-417, 1998.
16. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by nephrologist. Am J Kidney Dis 28: 841-845, 1996.
17. 7. Arora P, Obrador GT, Ruthazer R, Kausz AMT, Meye KB, Jenuleson CS, Pereira BJG: Prevalence, predictors, and consequences of late nephrology referral al a tertiary care center. J Am Soc Nephrol 10: 1281-1286, 1999.
18. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche T, Man NK. Late referral to maintenance dialysis: detriemental consequences. Nephrol Dial Transplant 8: 1089-1093, 1993.
19. Sesso R, Belasco AG: Late diagnosis of chronic renal failure and mortality on mantenace dialysis. Nephrol Dial Transplant 11: 2417-2420, 1996.
20. Jungers P, Massy Z, Nguyen-Khoa T, Choukroun G, Robino C, Fakhouri G, Touam M, Nguyen AT, Grünfeld JP. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 16: 2357-2364, 2001.
21. Innes A, Rowe PA, Burden RP, Morgan AG: Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant 7: 467-471, 1992.
22. Lamiere N, Van Biesen W: The pattern of referral of patients with end-stage renal disease to the nephrologist-a European survey. Nephrol Dial Transplant 14 (Supl. 6): 16-23, 1999.
23. Roubicek C, Brunnet P, Huiart L, Thirion X, Leonetti F, Dussol B, Jaber K, Andrieu D, Rammananarivo P, Berland Y: Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 36: 35-41, 2000.
24. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G: Early referral and its impact on emergent first dialyses, health care cost, and outcome. Am J Kidney Dis 32: 278-283, 1998.
25. Khan IH, Catto GRD, Edward N, Fleming LW, Henderson IS, MacLeod AM: Influence of coexisting disease on survival in renal-replacement therapy. Lancet 341: 415-418, 1993.
26. Sahn DJ, DeMaria A, Kisslo J, Weyman A: The committee on M-mode standardization of the American Society of echocardiography: recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1081, 1978.
27. Devereux RB: Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization and comparison to other methods. Hypertension 9 (Supl.): S19-S26, 1987.
28. Pombo JF, Troy BL, Russell RO: Left ventricular volumes and ejection fraction by echocardiography. Circulation 43: 480-490, 1971.
29. Levy D, Savage DD, Garrison RJ, Keven MA, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59: 956-960, 1987.
30. Huwez FU, Pringle SD, MacFarlane PW: A new classification of left ventricular geometry in patient with cardiac disease based on M-mode echocardiography. Am J Cardiol 70: 681-688, 1992.
31. Jungers P, Chiukroen G, Robino C, Massy Z, Taupin P, Labrunie M, Man NK, Landais P: Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant 15: 2000-2006, 2000.
32. Jungers P, Zingraff J, Page B, Albouze G, Hannedouche T, Man NK: Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int 43 (Supl. 41): 170-173, 1993.
33. Górriz JL, Sancho A, Ávila A, Amoedo ML, Martin M, Sanz P, Barril G, Salgueira M, De la Torre M: Efecto de la remisión tardía a nefrología: análisis de las condiciones de inicio de diálisis, morbilidad, mortalidad y costos. Estudio multicéntrico. Nefrología 20 (Supl. 4): 92, 2000.
34. Eadington DW: Delayed referral for dialysis. Nephrol Dial Transplant 11: 2124-2126, 1996.
35. Pereira BJG: Optimization of pre-ESRD care: the key to improved dialysis outcome. Kidney Int 57: 351-365, 2000.
36. Levey AS: Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? Am J Kidney Dis 32 (Supl. 3): 5-13, 1998.
37. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 157: 2413-2446, 1997.
38. Working Party for European best practice guidelines for the management of anaemia in patient with chronic renal failure. Nephrol Dial Transplant 14 (Supl. 5): 1-50, 1999.
39. European survey on anaemia management: Nephrol Dial Transplant 15 (Supl. 4): 1-76, 2000.
40. Górriz JL, Sancho A, Pallardó LM, Amoedo ML, Martín M, Sanz P, Barril G, Selgas R, Salgueira M, Palma A, De la Torre M, Ferreras I: Significado pronóstico de la diálisis programada en pacientes que inician tratamiento sustitutivo renal. Un estudio multicéntrico español. Nefrología 22: 49-59, 2002.
41. Coresh J, Wei L, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the united states. Findings from the third national health and nutrition examination survey (1988-1994). Arch Intern Med 161: 1207-1216, 2001.
42. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and Echocardiographic disease in end - stage renal disease. Kidney Int 47: 186-192, 1995.